Skip to Main Content

Advertisement

American Association for Cancer Research Logo
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 1, Issue 3
December 2021
Cancer Research Communications Cover Image for Volume 1, Issue 3
All Issues
EISSN 2767-9764
Combinatorial Natural Killer Cell–based Immunotherapy Approaches Selectively Target Chordoma Cancer Stem Cells
Austin T.K. Hoke; Michelle R. Padget; Kellsye P. Fabian; Anjali Nandal; Gary L. Gallia; Marijo Bilusic; Patrick Soon-Shiong; James W. Hodge; Nyall R. London, Jr.
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window
Influence of Germline BRCA Genotype on the Survival of Patients with Triple-Negative Breast Cancer
Cynthia Villarreal-Garza; Ana S. Ferrigno; Alejandro Aranda-Gutierrez; Paul H. Frankel; Nora H. Ruel; Alan Fonseca; Steven Narod; Yanin Chavarri-Guerra; Erika Sifuentes; Maria Cristina Magallanes-Hoyos; Josef Herzog; Danielle Castillo; Rosa M. Alvarez-Gomez; Alejandro Mohar-Betancourt; Jeffrey N. Weitzel
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window
Sex- and Mutation-Specific p53 Gain-of-Function Activity in Gliomagenesis
Nathan C. Rockwell; Wei Yang; Nicole M. Warrington; Max V. Staller; Malachi Griffith; Obi L. Griffith; Christina A. Gurnett; Barak A. Cohen; Dustin Baldridge; Joshua B. Rubin
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window
The ADAM17-directed Inhibitory Antibody MEDI3622 Antagonizes Radiotherapy-induced VEGF Release and Sensitizes Non–Small Cell Lung Cancer for Radiotherapy
Fabienne Tschanz; Sabine Bender; Irma Telarovic; Verena Waller; Roberto F. Speck; Martin Pruschy
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window
Tumor Suppressor PLK2 May Serve as a Biomarker in Triple-Negative Breast Cancer for Improved Response to PLK1 Therapeutics
Yang Gao; Elena B. Kabotyanski; Jonathan H. Shepherd; Elizabeth Villegas; Deanna Acosta; Clark Hamor; Tingting Sun; Celina Montmeyor-Garcia; Xiaping He; Lacey E. Dobrolecki; Thomas F. Westbrook; Michael T. Lewis; Susan G. Hilsenbeck; Xiang H.-F. Zhang; Charles M. Perou; Jeffrey M. Rosen
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Open the PDF for in another window

Advertisement

Email alerts

eTOC Alert
Close Modal
Latest News
Cancer Throughlines: Almost 20 Years On, HPV Vaccine Still Surpasses Expectations
Q&A: Lillian Siu and Matthew Vander Heiden Share Insights from the Forefront
Bispecific Bridge Helps NK Cells Target Lymphoma
View more recent articles
Breaking
Penpulimab OK’d for Nasopharyngeal Carcinoma
Former NCI Director to Lead Ohio Cancer Center
View more recent articles
Research Watch
Dietary Fat Promotes Triple-Negative Breast Cancer through FABP5–mTOR
ROS Sensing Regulates Mitochondrial Translation and Chemotherapy Response
View more recent articles
Spectral Flow Cytometry Methods and Pipelines for Comprehensive Immunoprofiling of Human Peripheral Blood and Bone Marrow
23ME-01473, an Fc Effector–Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell–Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation
Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting
Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck.  None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 2767-9764

AACR Journals

 

 

  • Copyright © 2025 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept